Next-Generation Antiviral Therapeutics: Bridging Innovation and Medicinal Chemistry
From 25 to 26 September 2025
Antiviral discovery and design is rapidly evolving into a dynamic, AI-assisted discipline at the intersection of medicinal chemistry, structural biology, and virology. As viral diseases continue to pose major global health threats, the demand for innovative therapeutic strategies has never been more urgent.
This meeting will spotlight the latest breakthroughs and forward-thinking approaches in antiviral drug discovery. Attendees will engage with leading european experts from academic research, funding institutions and biotechs, all dedicated to the identification, design and development of next-generation antiviral therapies. The event will also showcase contributions from early-career researchers and other key innovators in antiviral research.
By bringing together a diverse community of researchers and stakeholders this meeting aims to catalyze innovation and collaboration, and accelerate the translation of scientific advances into effective antiviral treatments.
Registration is free but mandatory.
The official launch ceremony for the Partnership is scheduled for 17 February 2026 in Paris, France.
11 December 2025